Objectives
- Summarize key insights from the survivor stories and identify at least one actionable takeaway to integrate into practice.
- Identify one key insight from group discussions and outline a next step for the organization or Action Team
- Explain the significance of HPV immunization and propose one practical approach to increase vaccination rates in their practice
- Evaluate current strategies for breast, lung, and colorectal cancer screening and access-to- care projects, and generate one idea for improvement in practice
- Demonstrate understanding of motivational interviewing by drafting two questions to support tobacco or alcohol cessation.
Presentations
North Dakota Cancer Coalition (Day 1)
North Dakota Colorectal Cancer Roundtable (Day 2)
Sponsorship and Vendors
Is your organization interested in sponsoring this or other activities? You can Become a Sponsor or Contact Us for more information.
Our Sponsors
PharmaEssentia
PharmaEssentia is a biopharmaceutical company committed to advancing treatments for hematologic disorders and oncology through innovative biologic therapies.
Bismarck Cancer Center
Bismarck Cancer Center provides comprehensive oncology care, offering advanced cancer treatment services close to home for patients in the region.
Deciphera
Deciphera is a biopharmaceutical company focused on discovering and developing targeted therapies for patients with cancer, particularly those with difficult-to-treat tumors.
Gilead Sciences
Gilead Sciences is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases, including cancer, HIV, liver disease, and inflammation.
Women’s Way
Women’s Way is North Dakota’s Breast and Cervical Cancer Early Detection Program, providing eligible women with access to free or low‑cost breast and cervical cancer screenings, diagnostic services, and patient navigation to help overcome barriers to care. The program is administered by North Dakota Health and Human Services in partnership with local public health agencies statewide.
GSK
GSK is a global biopharma company focused on vaccines, specialty medicines, and general medicines to prevent and treat disease and improve quality of life.
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development and delivery of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast, lung and gastric cancer, tenosynovial giant cell tumor and iron deficiency anemia. Visit us at www.daiichisankyo.us.
Pharmacosmos Therapeutics
Pharmacosmos Therapeutics specializes in iron deficiency therapies, developing treatments to improve outcomes for patients with chronic disease-related iron deficiency.
Syndax
Syndax is a clinical-stage biopharmaceutical company developing epigenetic therapies to treat cancer, focused on addressing areas of high unmet medical need.
Guardant Health
Guardant Health is a precision oncology company developing blood‑based and tissue genomic testing solutions to help detect cancer early, guide treatment decisions, and improve patient outcomes.
Tempus AI
AI-enabled precision medicine: Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.